{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993464232064.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/0167-5699(88)91239-x"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:016756998891239X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:016756998891239X?httpAccept=text/plain"}},{"identifier":{"@type":"NAID","@value":"30004423320"}}],"dc:title":[{"@value":"T- and B-cell recognition of hepatitis B viral antigens"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993464232064","@type":"Researcher","foaf:name":[{"@value":"David R. Milich"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01675699"},{"@type":"NCID","@value":"AA10622895"}],"prism:publicationName":[{"@value":"Immunology Today"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1988-12","prism:volume":"9","prism:number":"12","prism:startingPage":"380","prism:endingPage":"386"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:016756998891239X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:016756998891239X?httpAccept=text/plain"}],"createdAt":"2003-03-25","modifiedAt":"2024-12-12","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285714609541632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Applications of human hepatitis B virus preS domain in bio- and nanotechnology"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846642491660416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572699411915136","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy of hepatitis B vaccines with and without preS2-region product in Sumo wrestlers in Japan"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/0167-5699(88)91239-x"},{"@type":"CIA","@value":"30004423320"},{"@type":"CROSSREF","@value":"10.3748/wjg.v21.i24.7400_references_DOI_5mmPW8j0j46xBZpoANsWdnLrp8O"},{"@type":"CROSSREF","@value":"10.1093/hmg/ddr301_references_DOI_5mmPW8j0j46xBZpoANsWdnLrp8O"}]}